An analysis of 19 causes of death in the United States revealed persistent disparities and a familiar pattern across five racial-ethnic groups and 3,110 counties from 2000 to 2019. That’s according to the most comprehensive peer-reviewed research published today in The Lancet.
FDA approves Daiichi Sankyo’s new first-line AML drug quizartinib with boxed warning for heart disorders
Patients with a rarer form of acute myeloid leukemia now have a frontline treatment option for the first time, thanks to the FDA’s approval of
July 22, 2023